LV11816B - Implant compositions containing a biologically active protein, peptide or polypeptide - Google Patents

Implant compositions containing a biologically active protein, peptide or polypeptide

Info

Publication number
LV11816B
LV11816B LVP-97-37A LV970037A LV11816B LV 11816 B LV11816 B LV 11816B LV 970037 A LV970037 A LV 970037A LV 11816 B LV11816 B LV 11816B
Authority
LV
Latvia
Prior art keywords
biologically active
peptide
polypeptide
active protein
compositions containing
Prior art date
Application number
LVP-97-37A
Other languages
English (en)
Other versions
LV11816A (lv
Inventor
Steber William David
Cady Susan Mancini
Johnson David Farley
Rice Theresa
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of LV11816A publication Critical patent/LV11816A/xx
Publication of LV11816B publication Critical patent/LV11816B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/10—Stiffening bandages containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
LVP-97-37A 1991-06-24 1997-03-05 Implant compositions containing a biologically active protein, peptide or polypeptide LV11816B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71989891A 1991-06-24 1991-06-24

Publications (2)

Publication Number Publication Date
LV11816A LV11816A (lv) 1997-08-20
LV11816B true LV11816B (en) 1997-12-20

Family

ID=24891827

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-37A LV11816B (en) 1991-06-24 1997-03-05 Implant compositions containing a biologically active protein, peptide or polypeptide

Country Status (24)

Country Link
EP (1) EP0523330B1 (fr)
JP (1) JP3597205B2 (fr)
KR (1) KR100221031B1 (fr)
CN (1) CN1050301C (fr)
AT (1) ATE135565T1 (fr)
AU (1) AU656200B2 (fr)
BR (1) BR9202374A (fr)
CA (1) CA2071757C (fr)
DE (1) DE69209173T2 (fr)
DK (1) DK0523330T3 (fr)
ES (1) ES2087337T3 (fr)
GE (1) GEP19970992B (fr)
GR (1) GR3019457T3 (fr)
HU (1) HU217547B (fr)
IE (1) IE74398B1 (fr)
IL (1) IL102287A (fr)
LV (1) LV11816B (fr)
MD (1) MD1394G2 (fr)
MX (1) MX9203175A (fr)
RU (1) RU2080119C1 (fr)
SG (1) SG47955A1 (fr)
TW (1) TW215058B (fr)
UA (1) UA26137C2 (fr)
ZA (1) ZA924613B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
CA2336879C (fr) 1998-07-20 2010-06-01 Peptech Limited Compositions a liberation prolongee contenant des peptides, des polypeptides, des proteines ou des acides nucleiques comme principes actifs
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
KR20090007504A (ko) 2000-02-24 2009-01-16 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들
KR20030023878A (ko) 2000-06-26 2003-03-20 몬산토 테크놀로지 엘엘씨 소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
JP2005145821A (ja) * 2003-11-11 2005-06-09 Kao Corp 打錠製剤
JP2013515080A (ja) 2009-12-21 2013-05-02 アンブルックス，インコーポレイテッド 修飾されているウシのソマトトロピンポリペプチドおよびそれらの使用
AU2010341518B2 (en) 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
CA1257199A (fr) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation contenant une substance macromoleculaire ayant des proprietes biologiques liberee pendant plusieurs mois in vivo
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
EP0542915A1 (fr) * 1990-08-09 1993-05-26 Endocon, Inc. Systeme d'administration de medicaments multiples

Also Published As

Publication number Publication date
MD1394G2 (ro) 2000-11-30
BR9202374A (pt) 1993-01-26
IL102287A (en) 2000-06-01
AU656200B2 (en) 1995-01-27
KR930000131A (ko) 1993-01-15
CA2071757A1 (fr) 1992-12-25
ZA924613B (en) 1993-03-31
IE922020A1 (en) 1992-12-30
HUT61486A (en) 1993-01-28
IE74398B1 (en) 1997-07-30
JP3597205B2 (ja) 2004-12-02
DE69209173T2 (de) 1996-11-28
JPH05186363A (ja) 1993-07-27
ATE135565T1 (de) 1996-04-15
ES2087337T3 (es) 1996-07-16
HU217547B (hu) 2000-02-28
CA2071757C (fr) 2003-06-10
MD1394F2 (en) 2000-01-31
EP0523330A1 (fr) 1993-01-20
UA26137C2 (uk) 1999-06-07
DE69209173D1 (de) 1996-04-25
SG47955A1 (en) 1998-04-17
CN1068965A (zh) 1993-02-17
AU1847092A (en) 1993-01-07
GR3019457T3 (en) 1996-06-30
DK0523330T3 (da) 1996-04-15
GEP19970992B (en) 1997-11-20
RU2080119C1 (ru) 1997-05-27
KR100221031B1 (ko) 1999-09-15
IL102287A0 (en) 1993-01-14
MX9203175A (es) 1993-04-01
TW215058B (fr) 1993-10-21
HU9202092D0 (en) 1992-09-28
MD940370A (en) 1996-06-28
LV11816A (lv) 1997-08-20
CN1050301C (zh) 2000-03-15
EP0523330B1 (fr) 1996-03-20

Similar Documents

Publication Publication Date Title
EP0212474A3 (fr) Peptides osseux morphogénétiques
FI101938B1 (fi) Polypeptidijohdannaisia
ZA941771B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GR3021708T3 (en) Human vascular permeability factor
GR3030382T3 (en) Cytokine restraining agents.
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
EP0162813A3 (en) Pharmaceutical compositions containing a dipeptide
IL102287A (en) Implant compositions containing a biologically continuous active protein peptide or polypeptide
GR3032775T3 (en) Modified protein and peptide pharmaceuticals
EP0383837A4 (en) Alveolar surfactant proteins
GR3031927T3 (en) Cysteine depleted il-6 muteins
DE69528531D1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
ATE366310T1 (de) Menschliches chondromodulin-i-protein
DE69002881D1 (de) Peptide und deren Benutzung.
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
NZ220325A (en) Implants containing peptide or protein medicament in permeable polymeric coating
EP0723016A3 (fr) Facteur d'activation des leukocytes
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
EP0446100A3 (en) Method for the quantitative determination of the biologically active form of the human nerve growth factor in protein liquids